Tuesday, April 10, 2018

Pharma Reviews: US To Keep Mounting Pressure On India To Withdraw Price Caps On Medical Devices

In February 2017, the National Pharmaceutical Pricing Authority (NPPA) capped prices of coronary stents to reduce prices by as much as 85%. The price of drug-eluting or drug-coated stents — the most commonly used in India — were cut from around Rs 2 lakh to around Rs 30,000. The NPPA found ...
Read more: US To Keep Mounting Pressure On India To Withdraw Price Caps On Medical Devices